explore -WSS

explore

author：explore 2025-09-06 02:14:16 - browse：39296

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： 'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

WSS

Are infertility treatments 'essential' during the Covid

Can CDC director Mandy Cohen drive consensus in Washington?

Mike Pence clashes with Tucker Carlson in Iowa

Delta passengers in Vegas fall sick while waiting on flight in triple

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Argenx drug significantly slows progression of nerve disorder

entertainment

explore

hotspot

How to save PrEP access — and even expand it

Are infertility treatments 'essential' during the Covid

Moonlake's readout produced a cash windfall. Risks remain

Does aspartame cause cancer? What new WHO guidance says

Psychedelics group wrestles with new pharma identity

When a patient nears the end, a feared therapy can comfort

United colonoscopy coverage change 'may cost lives,' doctors say

Telehealth startups are trying to fill the menopause care vacuum

Peter Hotez and the public health issue of online harassment

In rare move, senator releases unverified FBI source report alleging Biden bribe

knowledge

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Stanford president’s abrupt resignation sparks debate

Georgia court denies Trump's request to quash DA's 2020 election probe

Europe sees delivery challenges ahead on Alzheimer's therapies

Europe sees delivery challenges ahead on Alzheimer's therapies

focus

hotspot

entertainment

leisure time